18 results
10-K
2023 FY
TSBX
Turnstone Biologics Corp
21 Mar 24
Annual report
8:51pm
and identifies any potential risk to public health or the environment, and such review may result in some delay before initiation of a clinical trial … operations. If our operations result in contamination of the environment or expose individuals to hazardous substances, we could be liable
10-Q
2023 Q2
TSBX
Turnstone Biologics Corp
1 Sep 23
Quarterly report
4:39pm
materially from those projected in the forward-looking statements. Moreover, we operate in an evolving environment. New risk factors and uncertainties may … in the current environment of healthcare reform. Federal, state and foreign enforcement bodies have recently increased their scrutiny of interactions between
424B4
qn0qsr8y7 y0
21 Jul 23
Prospectus supplement with pricing info
7:14pm
S-1/A
7q650choxnjfe2
23 Jun 23
IPO registration (amended)
9:49pm
CORRESP
3ayz lj4lss
21 Jun 23
Correspondence with SEC
12:00am
S-1
EX-10.9
gxjhjb
12 Jun 23
IPO registration
4:28pm
S-1
oy5rxzgwbwvta 2x32
12 Jun 23
IPO registration
4:28pm
S-1
EX-10.8
kp6psq0 xv71
12 Jun 23
IPO registration
4:28pm
S-1
EX-2.1
zoi9 3zhqjvpo
12 Jun 23
IPO registration
4:28pm
DRS
EX-2.1
3c976v5f9ck419439wmy
15 May 23
Draft registration statement
12:00am
DRS
EX-10.9
79653ekc4jvn877revu
15 May 23
Draft registration statement
12:00am
DRS
EX-10.8
unvtr
15 May 23
Draft registration statement
12:00am
DRS
6fdozd
15 May 23
Draft registration statement
12:00am
- Prev
- 1
- Next